Literature DB >> 14516753

Glucose and type 2A protein phosphatase regulate the interaction between catalytic and regulatory subunits of AMP-activated protein kinase.

José V Gimeno-Alcañiz1, Pascual Sanz.   

Abstract

We have expressed in yeast the different subunits of AMP-activated protein kinase (AMPK) and, by using the two-hybrid system, we have found a glucose-regulated interaction between alpha 2 catalytic and gamma 1 regulatory subunits. This regulation was not affected by known regulators of the corresponding yeast orthologue, the SNF1 complex, such as Reg1 or Hxk2, but it was affected by deletion of regulatory subunits of yeast type 2A protein phosphatase (PP2A) complex. We have also found that Tpd3 and PR65 alpha, the corresponding yeast and mammalian A subunits of PP2A, interacted with AMPK alpha 2 both in yeast and mammals, respectively. This interaction occurred only through the regulatory domain of this subunit. These results suggested a direct involvement of PP2A complex in regulating the interaction between AMPK alpha 2 and gamma 1 in a glucose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516753     DOI: 10.1016/j.jmb.2003.08.022

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

Review 1.  Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?

Authors:  Asish K Saha; X Julia Xu; Thomas W Balon; Amanda Brandon; Edward W Kraegen; Neil B Ruderman
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 2.  Alcoholic-induced hepatic steatosis--role of ceramide and protein phosphatase 2A.

Authors:  Rodjawan Supakul; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2011-04-20       Impact factor: 7.012

3.  Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.

Authors:  Biny K Joseph; Hsing-Yin Liu; Jamie Francisco; Devanshi Pandya; Melissa Donigan; Christina Gallo-Ebert; Caroline Giordano; Adam Bata; Joseph T Nickels
Journal:  J Biol Chem       Date:  2015-02-18       Impact factor: 5.157

4.  Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.

Authors:  Carlos Romá-Mateo; Maria Del Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Vikas V Dukhande; Jordi Donderis; Carolyn A Worby; Alberto Marina; Olga Criado; Antonius Koller; Santiago Rodriguez De Cordoba; Matthew S Gentry; Pascual Sanz
Journal:  Biochem J       Date:  2011-10-15       Impact factor: 3.857

Review 5.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

6.  The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits.

Authors:  Daniel Moreno; Mhairi C Towler; D Grahame Hardie; Erwin Knecht; Pascual Sanz
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

Review 7.  AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function.

Authors:  Ming-Hui Zou; Yong Wu
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-12-26       Impact factor: 2.557

Review 8.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

9.  AMPK Protein Interaction Analyses by Yeast Two-Hybrid.

Authors:  Pascual Sanz; Rosa Viana; Maria Adelaida Garcia-Gimeno
Journal:  Methods Mol Biol       Date:  2018

Review 10.  Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.

Authors:  Mingo M H Yung; Hextan Y S Ngan; David W Chan
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-01-12       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.